DE69228674D1 - Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung - Google Patents

Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung

Info

Publication number
DE69228674D1
DE69228674D1 DE69228674T DE69228674T DE69228674D1 DE 69228674 D1 DE69228674 D1 DE 69228674D1 DE 69228674 T DE69228674 T DE 69228674T DE 69228674 T DE69228674 T DE 69228674T DE 69228674 D1 DE69228674 D1 DE 69228674D1
Authority
DE
Germany
Prior art keywords
decongestir
nonsteroidal anti
drug
containing ophthalmic
inflammatory drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69228674T
Other languages
English (en)
Other versions
DE69228674T2 (de
Inventor
Federico Stroppolo
Daniele Bonadeo
Luigi Vigano
Annibale Gazzaniga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Application granted granted Critical
Publication of DE69228674D1 publication Critical patent/DE69228674D1/de
Publication of DE69228674T2 publication Critical patent/DE69228674T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69228674T 1991-11-27 1992-11-25 Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung Expired - Fee Related DE69228674T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913170A IT1252692B (it) 1991-11-27 1991-11-27 Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi

Publications (2)

Publication Number Publication Date
DE69228674D1 true DE69228674D1 (de) 1999-04-22
DE69228674T2 DE69228674T2 (de) 1999-07-15

Family

ID=11361205

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69228674T Expired - Fee Related DE69228674T2 (de) 1991-11-27 1992-11-25 Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung

Country Status (6)

Country Link
US (1) US5459157A (de)
EP (1) EP0550921B1 (de)
AT (1) ATE177633T1 (de)
DE (1) DE69228674T2 (de)
ES (1) ES2131517T3 (de)
IT (1) IT1252692B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US6769428B2 (en) 1997-01-29 2004-08-03 Peter J. Cronk Adhesively applied external nasal strips and dilators containing medications and fragrances
US20060029653A1 (en) 1997-01-29 2006-02-09 Cronk Peter J Therapeutic delivery system
US6550474B1 (en) 1997-01-29 2003-04-22 Cns, Inc. Microencapsulated fragrances and methods of coating microcapsules
US6090403A (en) * 1998-08-17 2000-07-18 Lectec Corporation Inhalation therapy decongestant with foraminous carrier
BR0109317A (pt) * 2000-07-14 2003-06-17 Allergan Inc Composições contendo componentes agonistas alfa-2-adrenérgicos
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
ITRM20010048A1 (it) 2001-01-30 2002-07-30 Gregorio Mauro De Metodo per preparare soluzioni acquose fisiologicamente accettabili esoluzioni cosi' ottenute.
BG65734B1 (bg) * 2002-02-22 2009-09-30 Био Терапютикс - Еоод Течен мукоадхезивен фармацевтичен състав
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
AU2003261304A1 (en) 2002-07-30 2004-02-16 Omeros Corporation Ophthalmologic irrigation solutions and method
EP2481412B1 (de) * 2004-05-25 2017-09-27 Galderma Pharma S.A. Verbindungen, Formulierungen und Verfahren zur Behandlung oder Vorbeugung entzündlicher Hautstörungen
DK1885336T3 (da) * 2005-05-10 2009-05-25 Alcon Inc Suspensionsformuleringer, der omfatter et aktivt princip, et overfladeaktivt poloxamer- eller meroxapolmiddel og en glycol, samt deres anvendelse til fremstilling af et medikament til behandling af öjenlidelser
CA2662018A1 (en) 2006-08-30 2008-03-06 David William Smith Method of imparting a mono-axial or multiaxial stiffness to extruded materials and products resulting therefrom
US20120202863A1 (en) * 2011-02-03 2012-08-09 Gerald Horn Compositions and methods for treatment of glaucoma
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734222A (en) * 1986-04-03 1988-03-29 Ciba-Geigy Corporation Composition and method for cleaning soft and hard contact lenses
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
US4996209A (en) * 1988-06-20 1991-02-26 Alcon Laboratories, Inc. Ophthalmic antiinflammatory compositions comprising S(+)-flurbiprofen
US4988728A (en) * 1989-11-03 1991-01-29 Alcon Laboratories, Inc. Suprofen esters and amides as ophthalmic anti-inflammatory agents
US5077033A (en) * 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide

Also Published As

Publication number Publication date
ITMI913170A1 (it) 1993-05-28
ATE177633T1 (de) 1999-04-15
ES2131517T3 (es) 1999-08-01
EP0550921A1 (de) 1993-07-14
DE69228674T2 (de) 1999-07-15
IT1252692B (it) 1995-06-23
ITMI913170A0 (it) 1991-11-27
EP0550921B1 (de) 1999-03-17
US5459157A (en) 1995-10-17

Similar Documents

Publication Publication Date Title
DE69228674T2 (de) Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung
ATE130758T1 (de) Arzneimittel zur intranasalen verabreichung, die ketorolac r enthalten.
ATE79619T1 (de) Arzneimittel.
ATE201989T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe
ATE87471T1 (de) Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz.
ATE134134T1 (de) Feste arzneizubereitungen zur oralen verabreichung mit verlängerter magenverweilzeit
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
ATE84373T1 (de) Bedingte dosierungsvorrichtung.
BR9606863A (pt) Líquidos para mascarar o sabor
ES2125342T3 (es) Esteres y combinaciones de un nitrato organico y de un salicilato.
GB9212450D0 (en) New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
DE60142305D1 (de) Pharmazeutische zubereitung enthaltend n-ä2-(1,6,7,8-tetrahydro-2h-indenoä5,4 büfuran-8-yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung
DE69521924D1 (de) Pharmazeutische Darreichungsformen mit verzögerter Wirkstoffabgabe enthaltend Alfuzosinhydrochlorid
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
DE69106892D1 (de) Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit.
DE69214333D1 (de) Arzneizubereitung mit hohem Gehalt an Ibuprofenlysinat
EP0535250A4 (en) Novel compounds and use thereof as medicine
DE69300296D1 (de) Thiochromanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
DE59501945D1 (de) Orale Arzeimittelzubereitung enthaltend Diclofenac-Natrium und eine organische Säure
ITRM910550A0 (it) Preparazioni farmaceutiche orali, a base di acidi biliari, a cessione protratta e controllata con le quali e' possibile adottare una sola somministrazione giornaliera
NO155620C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo(a,d)-cyklohepten-derivater.
DE69325531T2 (de) Oral anzuwendendes Arzneimittel bestehend aus Ibuprofen
TH19526A (th) วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee